Levetiracetam chemical structure of levetiracetam

Find information on thousands of medical conditions and prescription drugs.

Levetiracetam

Levetiracetam (brand name: Keppra®) is an anticonvulsant medication used to treat epilepsy. It is S- enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam (Nootropil®). Along with other anticonvulsants like gabapentin (Neurontin®), it is also sometimes used to treat neuropathic pain. more...

Home

Lamisil

Lantus

Lariam

Larotid

Lasix

Lescol

Leucine

Levitra

Levora

Levoxyl

Levulan

Lexapro

Lexiva

Librium

Lidopen

Lipidil

Lipitor

Lithane

Lodine

Lomotil

Lortab

Lotrel

Lovenox

LSD

Lupron

Luvox

Luxiq

Theophylline

Side effects

Side effects include: ataxia (sudden loss of balance); hair loss; pins and needles sensation in the extremities; sudden, intense feelings of rage; vivid dreams; and many other common side effects like headache and nausea.

Read more at Wikipedia.org

• [List your site here Free!]


	Levetiracetam may avert transformed migraines.(Clinical Rounds) : An article from: Internal Medicine News $5.95	Levetiracetam controls seizures in refractory and elderly patients: two postmarketing studies.(Geriatric Psychiatry) : An article from: Clinical Psychiatry News $5.95

	Levetiracetam controls epilepsy in most adults.(Neuropsychiatric Medicine) : An article from: Clinical Psychiatry News $5.95


Levetiracetam Relieves Partial-Onset Seizures - Brief Article - Statistical Data Included ORLANDO, FLA. -- The antiepilepsy drug levetiracetam, approved in December by the Food and Drug Administration, is an effective add-on treatment for ... From Family Pratice News, 2/1/00 by Sharon Worcester

New Data on the Use of Keppra(R) (levetiracetam) as Adjunctive Treatment in Idiopathic Generalised Epilepsy Patients with Primary Generalised Tonic-Clonic Brussels, 6 December 2005: According to new data, presented at a UCB sponsored Scientific Exhibit at the 59th Annual Meeting of the American Epilepsy Society in Washington, DC, U.S., appr From Market Wire, 12/6/05

Regulatory Filing Submitted to FDA for Keppra(R) (levetiracetam) as Treatment for Myoclonic Seizures UCB Pharma, Inc. today announced that it filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) for the use ... From Market Wire, 10/27/05

Discontinuing valproate may reverse PCOS in some women BRECKENRIDGE, COLO. -- Hormonal evidence of polycystic ovary syndrome in patients on valproate is often reversed by a switch to one of the newer antiepileptic ... From OB/GYN News, 3/1/05

Treatment of migraine headache in children and adolescents The American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society have released a report on ... From American Family Physician, 3/1/05 by Carrie Morantz

Guidelines for prescribing antiepileptic drugs The American Academy of Neurology (AAN) has released evidence-based guidelines for prescribing new antiepileptic drugs (AEDs) in patients with new-onset ... From American Family Physician, 1/15/05

Identification and treatment of bronchoconstriction induced by a vagus nerve stimulator employed for management of seizure disorder We evaluated a 63-year-old woman who developed dyspnea with a sensation of chest tightness that was temporally associated with discharges from a vagus ... From CHEST, 1/1/05 by Jagdeep S. Bijwadia

Advances in antiepileptic drug treatments: a rational basis for selecting drugs for older patients with epilepsy Incidence of epilepsy increases rapidly after age 65; recent studies indicate that approximately 10% of nursing home residents are being treated with ... From Geriatrics, 12/1/04 by Ilo E. Leppik

Home

Contact

Resources

Exchange Links

ebay